Should you buy, hold, or sell these ASX 200 stocks?

Is the broker feeling bullish about these stocks? Let's find out.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There have been a lot of results releases this month from ASX 200 stocks.

But which results have gone down well with analysts at Morgans?

Let's take a look at three that the broker has been running the rule over and how it rates them:

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.

Image source: Getty Images

Bega Cheese Ltd (ASX: BGA)

This diversified food company's full year results were in line with expectations, with its cash flow generation a particular highlight.

And while it has stopped short of calling the ASX 200 stock a buy, it is recommending investors accumulate its shares with a price target of $6.08. This implies potential upside of 10.5% for investors. It said:

BGA's FY25 result was in line with expectations. Strong earnings growth was led by Bulk returning to strong profitability. Pleasingly, Branded proved resilient despite a more difficult operating environment. Cashflow performance was a highlight and gearing finished the year below BGA's target range. FY26 guidance was in line with expectations. Given its restructuring activity, BGA is on track to exceed its FY28 EBITDA target of A$250m. We think A$265m is now more likely. This underpins a strong growth profile across the forecast period. We have made modest upgrades to our forecasts. We have an Accumulate rating on BGA. The next catalyst is if BGA is successful in acquiring Fonterra's Oceania business.

Netwealth Group Ltd (ASX: NWL)

Another ASX 200 stock that Morgans has been looking at is investment platform provider Netwealth.

While its FY 2025 result was undoubtedly strong, it was a touch below expectations. As a result, the broker has retained its hold rating on its shares with a $35.48 price target. It said:

NWL reported FY25 Revenue +27%; EBITDA +31%; and NPAT +40% on pcp. The result was slightly below expectations on 2H cost growth, however there is no change to the strong underlying execution of the business. NWL gave FY26 guidance for net inflows to be similar (~A$15.8bn) and opex growth of ~19%. Strong embedded inflows continues to allow NWL to invest in capturing new market segments and still deliver >18% CAGR to FY28F. NWL's opportunity runway remains long and we expect the business to continue to execute. However, we view the valuation as full. HOLD recommendation.

Sandfire Resources Ltd (ASX: SFR)

Finally, Morgans believes this copper miner is close to being fully valued at current levels.

In response to its fourth quarter update, the broker has retained its hold rating on the ASX 200 stock with a $12.55 price target. It commented:

We update our FY25 statutory numbers for one-off adjustments flagged in its 4Q25 result. Additionally, we have adjusted our valuation methodology from a 100% DCF valuation to a blended 50:50 DCF:7x NTM EV/EBITDA valuation and as a result our target price increases to A$12.55ps (previously A$11.40ps). We rate SFR a HOLD with a A$12.55ps target price.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Netwealth Group. The Motley Fool Australia has positions in and has recommended Netwealth Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Person pressing the buy button on a smartphone.
Broker Notes

3 reasons to buy Pro Medicus shares today

A leading analyst believes Pro Medicus shares are now trading at a significant discount.

Read more »

Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.
Broker Notes

Buy, hold, sell: Sigma Healthcare, Macquarie, Santos shares

Brokers reveal their latest ratings and reviews on 3 ASX 200 stocks.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

Buy, hold, sell: Macquarie, Boss Energy, CBA shares

The market looks set to endure a sixth consecutive day in the red.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

Guess which ASX 200 share could rise 90% according to Bell Potter

Let's see what the broker is saying about this stock this week.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

These ASX 200 shares could rise 25% to 70%

Morgans expects big returns from these top stocks.

Read more »

ASX 200 shares broker downgrade origami paper fortune teller with buy hold sell and dollar sign options
Broker Notes

Down 42% in a year, are Boss Energy shares now a bargain buy?

A leading analyst provides his outlook for Boss Energy’s beaten down shares.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

2 ASX 200 shares Macquarie thinks will return nearly 30%

These two companies could be worth a closer look.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Ord Minnett says these ASX 300 shares are buys

The broker is feeling bullish about these shares right now.

Read more »